{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:09:50Z","timestamp":1792602590212,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.diabres.2024.111727","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:39:40Z","timestamp":1717605580000},"page":"111727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes"],"prefix":"10.1016","volume":"213","author":[{"given":"Lukas L.F.","family":"Hoes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-8124","authenticated-orcid":false,"given":"Niels P.","family":"Riksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-0589","authenticated-orcid":false,"given":"Johanna M.","family":"Geleijnse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.H.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"T. van der Schouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-5223","authenticated-orcid":false,"given":"Frank L.J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1487-1635","authenticated-orcid":false,"given":"Charlotte","family":"Koopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111727_b0005","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2024.111727_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.06.001","article-title":"Effect of anti-inflammatory therapy on major cardiovascular events in patients with diabetes: a meta-analysis","volume":"15","author":"Masson","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.diabres.2024.111727_b0015","doi-asserted-by":"crossref","unstructured":"Ridker, P. M. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection. Circulation Research vol. 118 145\u2013156 Preprint at DOI: 10.1161\/CIRCRESAHA.115.306656 (2016).","DOI":"10.1161\/CIRCRESAHA.115.306656"},{"key":"10.1016\/j.diabres.2024.111727_b0020","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of Interleukin-1\u03b2 and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial","volume":"76","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2024.111727_b0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratislava Medical Journal"},{"key":"10.1016\/j.diabres.2024.111727_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2703518","article-title":"Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis","volume":"2018","author":"Angkananard","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.diabres.2024.111727_b0035","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","article-title":"Which white blood cell subtypes predict increased cardiovascular risk?","volume":"45","author":"Horne","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2024.111727_b0040","doi-asserted-by":"crossref","unstructured":"Silvestre-Roig, C., Braster, Q., Ortega-Gomez, A. & Soehnlein, O. Neutrophils as regulators of cardiovascular inflammation. Nature Reviews Cardiology vol. 17 327\u2013340 Preprint at DOI: 10.1038\/s41569-019-0326-7 (2020).","DOI":"10.1038\/s41569-019-0326-7"},{"key":"10.1016\/j.diabres.2024.111727_b0045","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","article-title":"Neutrophil counts and cardiovascular disease","volume":"44","author":"Luo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2024.111727_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0202682","article-title":"Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease","volume":"13","author":"Kofink","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2024.111727_b0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/oby.23341","article-title":"Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome","volume":"30","author":"Levine","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.diabres.2024.111727_b0060","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease A LoDoCo2 proteomic substudy","volume":"142","author":"Opstal","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2024.111727_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jdiacomp.2016.10.029","article-title":"White blood cell subtypes and risk of type 2 diabetes","volume":"31","author":"Zhang","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2024.111727_b0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2024.111727_b0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db12-1625","article-title":"Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the advance study","volume":"63","author":"Lowe","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2024.111727_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01409-0","article-title":"Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes","volume":"20","author":"Sharif","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2024.111727_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01583-9","article-title":"High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study","volume":"21","author":"He","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2024.111727_b0090","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2024.111727_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066952","article-title":"Cohort profile: the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) Study-an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands","volume":"13","author":"Castelijns","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabres.2024.111727_b0100","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2007.009","article-title":"Linking laboratory and medication data: new opportunities for pharmacoepidemiological research","volume":"45","author":"ten Berg","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabres.2024.111727_b0105","first-page":"341","article-title":"Comparison of high-sensitivity C-reactive protein serum assay results obtained using Dade-Behring BNII nephelometer and Ortho Vitros FS 5.1 clinical analyzer in respect of CRP-related risk assessment of chronic metabolic diseases","volume":"54","author":"Kusnierz-Cabala","year":"2008","journal-title":"Clin Lab"},{"key":"10.1016\/j.diabres.2024.111727_b0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1076029615569568","article-title":"The relation between atherosclerosis and the neutrophil-lymphocyte ratio","volume":"22","author":"Balta","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.diabres.2024.111727_b0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/TCRM.S244623","article-title":"Neutrophil\u2013lymphocyte ratio (NLR) for predicting clinical outcomes in patients with coronary artery disease and type 2 diabetes mellitus: A propensity score matching analysis","volume":"16","author":"Qiao","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.diabres.2024.111727_b0120","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100009","article-title":"Regulatory T-cell Response to Low-Dose Interleukin-2 in ischemic heart disease","volume":"1","author":"Zhao","year":"2022","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.diabres.2024.111727_b0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MJT.0000000000001409","article-title":"Effect of colchicine in reducing inflammatory biomarkers and cardiovascular risk in coronary artery disease: a meta-analysis of clinical trials","volume":"30","author":"Sethuramalingam","year":"2023","journal-title":"Am J Ther"},{"key":"10.1016\/j.diabres.2024.111727_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther Adv Respir Dis"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724006375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724006375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T03:34:20Z","timestamp":1721446460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724006375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":26,"alternative-id":["S0168822724006375"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111727","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111727"}}